$INLX

TAGLICH ROBERT purchased $6K of INLX

TAGLICH ROBERT purchased 1,000 shares of INTELLINETICS, INC. (INLX) at an average of $5.52 ($5.00–$5.52) across 2 trades over 2026-08-27 to 2026-08-31.

Original reporting
SEC EDGAR · TAGLICH ROBERT
Published Sep 2, 2026, 1:46 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 2:24 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$INLX
Neutral
high confidence
Mentioned
$INLX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$INLXNeutralLow
01

Why it matters

The purchase adds to an existing 10% stake, but the dollar amount is negligible for market pricing.

02

Market read

Routine insider purchase; low trading relevance.

03

What to watch

Potential upcoming corporate actions not disclosed yet.

Relevance 4/10Novelty 4/10Timing: filed Sep 1, reported Sep 2

Background

Form 4 filings are primary disclosures of insider transactions required by the SEC.

Company-level read

Ticker impact

$INLXNeutralHigh confidence
Context

SEC Form 4 shows insider Robert Taglich bought 1,000 shares of Intellinetics for $5,522, increasing his stake to 455,338 shares.

Expected impact

minimal impact, possible slight positive bias

Evidence & confidence

Purchase size (~$5.5k) is trivial relative to market cap; insider already holds >10%.

Market effects

None; insider activity does not affect sector trends.

None; limited to Intellinetics shareholders.

None; micro‑cap insider trade has no global effect.

Counterpoint

Insider buying could signal confidence despite small size.

Key entities

  • Intellinetics, Inc.

    US‑listed biotech firm (ticker INLX).

  • Robert Taglich

    10% owner of Intellinetics.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$INLXMed

INTELLINETICS, INC. (INLX): Results of Operations and Financial Condition

INTELLINETICS, INC. (INLX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Intellinetics Reports Second Quarter and Six-Month 2026 Results COLUMBUS, OH – August 12, 2026 – Intellinetics, Inc. ( NYSE American: INLX ), a digital transformation solutions provider, announced financial results for the three and six months ended June 30, 2026. 20